This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
申请公布号
IL217013(D0)
申请公布日期
2012.02.29
申请号
IL20110217013
申请日期
2011.12.15
申请人
GLAXOSMITHKLINE BIOLOGICALS S.A.;ID BIOMEDICAL CORPORATION OF QUEBEC
